Speece Thorson Capital Group Inc. raised its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 0.5% during the second quarter, Holdings Channel reports. The fund owned 72,191 shares of the medical equipment provider’s stock after buying an additional 347 shares during the period. Zimmer Biomet Holdings comprises 1.9% of Speece Thorson Capital Group Inc.’s investment portfolio, making the stock its 29th largest position. Speece Thorson Capital Group Inc.’s holdings in Zimmer Biomet Holdings were worth $9,269,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in ZBH. BlackRock Inc. boosted its stake in shares of Zimmer Biomet Holdings by 4,042.4% in the first quarter. BlackRock Inc. now owns 16,740,383 shares of the medical equipment provider’s stock worth $2,044,168,000 after buying an additional 16,336,262 shares during the period. Harbour Capital Advisors LLC boosted its position in Zimmer Biomet Holdings by 13,131.3% in the second quarter. Harbour Capital Advisors LLC now owns 1,302,618 shares of the medical equipment provider’s stock valued at $10,145,000 after buying an additional 1,292,773 shares during the last quarter. Nordea Investment Management AB boosted its position in Zimmer Biomet Holdings by 25.0% in the first quarter. Nordea Investment Management AB now owns 4,931,281 shares of the medical equipment provider’s stock valued at $602,159,000 after buying an additional 987,398 shares during the last quarter. Glenview Capital Management LLC bought a new position in Zimmer Biomet Holdings during the first quarter valued at $94,197,000. Finally, Point72 Asset Management L.P. boosted its position in Zimmer Biomet Holdings by 230.3% in the first quarter. Point72 Asset Management L.P. now owns 1,053,500 shares of the medical equipment provider’s stock valued at $128,643,000 after buying an additional 734,500 shares during the last quarter. Institutional investors and hedge funds own 84.13% of the company’s stock.

Shares of Zimmer Biomet Holdings, Inc. (ZBH) opened at 117.93 on Friday. Zimmer Biomet Holdings, Inc. has a 52 week low of $95.63 and a 52 week high of $133.49. The firm has a market capitalization of $23.80 billion, a PE ratio of 33.59 and a beta of 1.20. The firm’s 50-day moving average is $127.65 and its 200 day moving average is $121.39.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.10 by $0.02. The business had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.95 billion. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The business’s revenue was up 1.1% on a year-over-year basis. During the same quarter last year, the business posted $2.02 earnings per share. On average, equities analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.24 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, July 28th. Stockholders of record on Friday, June 23rd were given a dividend of $0.24 per share. The ex-dividend date of this dividend was Wednesday, June 21st. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.81%. Zimmer Biomet Holdings’s dividend payout ratio (DPR) is presently 27.59%.

COPYRIGHT VIOLATION NOTICE: “Speece Thorson Capital Group Inc. Acquires 347 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/05/speece-thorson-capital-group-inc-acquires-347-shares-of-zimmer-biomet-holdings-inc-nysezbh.html.

ZBH has been the subject of several research analyst reports. Zacks Investment Research cut shares of Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a research note on Thursday, April 13th. Goldman Sachs Group, Inc. (The) began coverage on shares of Zimmer Biomet Holdings in a research note on Tuesday, May 16th. They issued a “sell” rating and a $92.00 price objective for the company. Canaccord Genuity reissued a “buy” rating on shares of Zimmer Biomet Holdings in a research note on Friday, April 28th. Wells Fargo & Company cut shares of Zimmer Biomet Holdings from an “outperform” rating to a “market perform” rating in a research note on Friday, April 28th. Finally, Morgan Stanley lifted their price objective on shares of Zimmer Biomet Holdings from $137.00 to $150.00 and gave the stock an “overweight” rating in a research note on Monday, July 17th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $137.76.

In other news, insider Sang Yi sold 17,731 shares of the firm’s stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $124.56, for a total transaction of $2,208,573.36. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Tony W. Collins sold 16,986 shares of the firm’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $121.74, for a total transaction of $2,067,875.64. The disclosure for this sale can be found here. Company insiders own 1.07% of the company’s stock.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.